ClinicalTrials.Veeva

Menu

Gaze Contingent Attentional Reinforcement in Major Depressive Disorder

T

Tel Aviv University

Status

Not yet enrolling

Conditions

Major Depressive Disorder (MDD)

Treatments

Behavioral: Aversive white noise
Behavioral: Music reward

Study type

Interventional

Funder types

Other

Identifiers

NCT07364981
TAU-MDD

Details and patient eligibility

About

The main objective of this randomized controlled trial is to evaluate whether a gaze-contingent feedback task using negative reinforcement can serve as an effective attention-modification procedure and contribute to the treatment of Major Depressive Disorder (MDD).

Full description

This randomized controlled trial uses a gaze-contingent attentional reinforcement task to modify attention allocation patterns to emotional stimuli in participants with Major Depressive Disorder. Specifically, participants will undergo 4 training sessions, during which either negative reinforcement (aversive white noise will be heard when gazing at sad faces) or positive reinforcement (music will be heard when gazing at happy faces) will be used to divert participants' gaze toward happy faces and away from sad faces. Depressive symptoms severity will be assessed before and after training (post-training and 3-month follow up) to examine changes (reduction) in symptom severity from before to after the intervention. Attention allocation will be assessed during training (i.e. online learning) as well as before and after training (i.e. transfer of learning).

Enrollment

60 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primary diagnosis of MDD
  • MADRS>=7
  • Normal or corrected-t-normal vision

Exclusion criteria

  • Present or past psychosis, manic or hypomanic episode, PTSD
  • High suicidal ideation or behavior
  • Severe alcohol or cannabis use disorder, and/or any severity of other substance use disorder (exepct nicotine use)
  • Pharmacological treatment if not stabilized for at least three months or concurrent psychotherapy
  • Current unstable or untreated medical illness
  • Current or past organic mental disorder, seizure or brain injury
  • Eye-tracking calibration difficulties
  • Post-ECT treatment

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

60 participants in 2 patient groups, including a placebo group

Gaze contingent negative reinforcement
Active Comparator group
Description:
participants will receive gaze-contingent negative reinforcement according to their viewing patterns
Treatment:
Behavioral: Aversive white noise
Gaze contingent positive reinforcement
Placebo Comparator group
Description:
participants will receive gaze-contingent positive reinforcement according to their viewing patterns
Treatment:
Behavioral: Music reward

Trial contacts and locations

1

Loading...

Central trial contact

Shani Lavi, M.A.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems